choline has been researched along with Lymph Node Metastasis in 103 studies
Excerpt | Relevance | Reference |
---|---|---|
"We aimed to assess the diagnostic accuracy of C-11 choline and C-11 acetate positron emission tomography/computed tomography (PET/CT) for lymph node (LN) staging in bladder cancer (BC) patients through a systematic review and meta-analysis." | 8.98 | Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis. ( Kim, IJ; Kim, K; Kim, SJ; Koo, PJ; Pak, K, 2018) |
"A 62-year-old patient with prostate adenocarcinoma underwent PET with radiolabeled choline (18F-Fcholine) for pretreatment staging of a high-risk prostate cancer." | 7.81 | Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer. ( De Clermont, H; Fernandez, P; Parrens, M; Pasticier, G; Pinaquy, JB, 2015) |
"The aim of this study was to evaluate the potential role of C-choline-PET/CT in nodal assessment in patients with bladder cancer (BCa) using the pathological specimen as reference standard." | 7.81 | 11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard. ( Bianchi, L; Castellucci, P; Ceci, F; Colletti, PM; Eugenio, B; Fanti, S; Graziani, T; Martorana, G; Pultrone, C; Rubello, D; Schiavina, R, 2015) |
"Prostate carcinoma is the most common cancer in men." | 5.46 | Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT. ( De Gersem, R; De Maeseneer, D; De Man, K; Van den Broeck, B, 2017) |
"A total of 72 patients with nodal prostate cancer relapse after primary therapy underwent pelvic and/or retroperitoneal salvage lymph node dissection." | 5.40 | Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography. ( Drendel, V; Grosu, AL; Henne, K; Hölz, S; Jandausch, A; Jilg, CA; Krauss, T; Reske, SN; Rischke, HC; Schultze-Seemann, W; Vach, W; Weber, WA; Wieser, G, 2014) |
"11C-choline PET was very effective in detecting lymph node metastases in the mediastinum originating from NSCLC, with a sensitivity of 100%." | 5.31 | Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. ( Hara, T; Inagaki, K; Kosaka, N; Morita, T, 2000) |
"We aimed to assess the diagnostic accuracy of C-11 choline and C-11 acetate positron emission tomography/computed tomography (PET/CT) for lymph node (LN) staging in bladder cancer (BC) patients through a systematic review and meta-analysis." | 4.98 | Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis. ( Kim, IJ; Kim, K; Kim, SJ; Koo, PJ; Pak, K, 2018) |
" Choline PET/CT (positron emission tomography/computed tomography) and magnetic resonance imaging (MRI) have been used for the evaluation of lymph node metastasis in patients with prostate cancer for the past decade." | 4.98 | Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer. ( Huang, SM; Li, YF; Lin, ZC; Yang, Y; Yin, L; Yue, JL, 2018) |
"A 65-year-old patient with prostate adenocarcinoma was explored by 18F-fluorocholine (FCH) PET/CT for pretreatment staging because of a high risk of prostate cancer." | 3.81 | Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT. ( Allard, JB; Cornelis, F; De Clermont, H; Pasticier, G; Pinaquy, JB, 2015) |
"A 62-year-old patient with prostate adenocarcinoma underwent PET with radiolabeled choline (18F-Fcholine) for pretreatment staging of a high-risk prostate cancer." | 3.81 | Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer. ( De Clermont, H; Fernandez, P; Parrens, M; Pasticier, G; Pinaquy, JB, 2015) |
"The aim of this study was to evaluate the potential role of C-choline-PET/CT in nodal assessment in patients with bladder cancer (BCa) using the pathological specimen as reference standard." | 3.81 | 11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard. ( Bianchi, L; Castellucci, P; Ceci, F; Colletti, PM; Eugenio, B; Fanti, S; Graziani, T; Martorana, G; Pultrone, C; Rubello, D; Schiavina, R, 2015) |
" Staging with (18)F-fluorocholine PET/CT ((18)F-FCH PET/CT) demonstrated lymph node metastasis." | 3.79 | Metastatic prostate cancer proven by 18F-FCH PET/CT staging scan in patient with normal PSA but high PSA doubling time. ( Cimitan, M; Fettich, J; Gubina, B; Hodolič, M; Maffione, AM; Rubello, D, 2013) |
"To assess the relationship between breast cancer subtypes and choline detection by using in vivo proton magnetic resonance (MR) spectroscopy and to assess the feasibility of proton MR spectroscopy in the study of axillary lymph node metastases." | 3.71 | Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. ( Tse, GM; Yang, WT; Yeung, DK, 2002) |
"Limited pelvic nodal relapse of prostatic cancer is a paramount challenge for locoregional salvage treatments." | 2.90 | Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07). ( Beckendorf, V; Buthaud, X; Campion, L; Créhange, G; De Laroche, G; Denis, F; Goineau, A; Hasbini, A; Lagrange, JL; Latorzeff, I; Loos, G; Palpacuer, C; Pasquier, D; Pommier, P; Rio, E; Sargos, P; Silva, M; Supiot, S; Vaugier, L, 2019) |
"Localized very high-risk prostate cancer (VHR PCa) has long suffered from the inex-istence of good lymph node staging methods other than invasive surgery, as computed tomogra-phy has low sensitivity for nodal disease." | 2.82 | Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer. ( Barbé, Y; Botelho, F; Cathelineau, X; Colandrea, G; Dias, N; Macek, P; Rodriguez-Sanchez, L, 2022) |
"Twelve prostate cancer patients (nine staging, three re-staging) were included." | 2.80 | BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study). ( Beheshti, M; Dinkelborg, L; Haim, S; Kunit, T; Langsteger, W; Loidl, W; Schiller, C; Stephens, A; Zakavi, R, 2015) |
"Lung cancers were analysed visually and semiquantitatively using the ratio of tumour-to-normal radioactivity (T/N ratio) and standardized uptake value (SUV)." | 2.71 | A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer. ( Endo, K; Higuchi, T; Inoue, T; Khan, N; Oriuchi, N; Sato, N; Tian, M; Zhang, H, 2003) |
"Oligorecurrent prostate cancer with exclusive nodal involvement represents a common state of disease, amenable to local therapy." | 2.61 | Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row : Nodal oligorecurrent prostate cancer. ( Castellucci, P; Ceci, F; Di Muzio, N; Fodor, A; Hoyer, M; Incerti, E; Ingrosso, G; Jereczek-Fossa, BA; Lancia, A; Ost, P; Picchio, M, 2019) |
"Choline PET/CT has shown limitations for the detection of primary prostate cancer and nodal metastatic disease, mainly due to limited sensitivity and specificity." | 2.49 | Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer. ( Gocke, Ch; Hildebrandt, G; Krause, BJ; Kuhnt, T; Kurth, J; Schwarzenböck, SM, 2013) |
"The role of PET imaging in prostate cancer is gradually evolving but still remains within the experimental realm." | 2.44 | Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse? ( Cascini, GL; Greco, C; Tamburrini, O, 2008) |
"We identified 124 consecutive prostate cancer patients from 2008 to 2018 with a solitary oligorecurrent metastatic lesion on positron emission tomography imaging who were treated with metastasis-directed therapy without androgen deprivation therapy from the Mayo Clinic C-11 choline registry." | 1.72 | Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer. ( Ahmed, ME; Andrews, JR; Boorjian, SA; Britton, C; Joshi, VB; Karnes, RJ; Kendi, AT; Kwon, ED; Phillips, R; Sharma, V; Sood, A; Stish, B; Tollefson, MK, 2022) |
"We identified all men with prostate cancer undergoing FCH PET/CT for initial staging followed by RALP and ePLND at Skåne University Hospital between 2015 and 2018." | 1.62 | A retrospective study assessing the accuracy of [18F]-fluorocholine PET/CT for primary staging of lymph node metastases in intermediate and high-risk prostate cancer patients undergoing robotic-assisted laparoscopic prostatectomy with extended lymph node ( Amidi, J; Anand, A; Bjartell, A; Bjöersdorff, M; Jiborn, T; Kjölhede, H; Puterman, C; Soller, W; Trägårdh, E, 2021) |
"In patients with high-risk prostate cancer, FCH PET and FCH PET/WBMRI depict significantly more metastatic lesions than do conventional imaging and WBMRI." | 1.48 | ( Berlin, A; Ghai, S; Halankar, J; Jhaveri, KS; Metser, U; Murphy, G; Tau, N, 2018) |
"Twenty Japanese prostate cancer patients underwent 11C-choline and FDG PET/CT before (n=5) or after (n=15) treatment." | 1.48 | Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer. ( Fujiwara, M; Fukushima, K; Hashimoto, T; Kamikonya, N; Kanematsu, A; Kitajima, K; Kobayashi, K; Nakanishi, Y; Nojima, M; Odawara, S; Suzuki, T; Yamada, Y; Yamakado, K; Yamamoto, S, 2018) |
"Post-treatment 11C-Choline-PET showed metabolic complete response in 17 metastases (44,7%), partial response in 9 metastases (38%)." | 1.46 | 11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. ( Chiti, A; D'Agostino, GR; Di Brina, L; Franzese, C; Lopci, E; Mancosu, P; Navarria, P; Scorsetti, M; Tomatis, S, 2017) |
"11C-choline-PET/CT-guided HTT is safe and effective in the treatment of LN relapses of prostate cancer in previously treated patients." | 1.46 | Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer. ( Berardi, G; Busnardo, E; Calandrino, R; Cozzarini, C; Dell'Oca, I; Di Muzio, NG; Fiorino, C; Fodor, A; Gianolli, L; Incerti, E; Kirienko, M; Mangili, P; Pasetti, M; Picchio, M, 2017) |
"Prostate carcinoma is the most common cancer in men." | 1.46 | Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT. ( De Gersem, R; De Maeseneer, D; De Man, K; Van den Broeck, B, 2017) |
"Two patients died of prostate cancer." | 1.42 | Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography. ( Bergstralh, EJ; Cheville, JC; DiMonte, G; Karnes, RJ; Kwon, ED; Lowe, VJ; Murphy, CR; Mynderse, LA, 2015) |
"Choline kinase is upregulated in prostate cancer, resulting in increased (18)F-fluoromethylcholine uptake." | 1.42 | Quantification of 18F-fluorocholine kinetics in patients with prostate cancer. ( Boellaard, R; Hendrikse, NH; Hoekstra, OS; Lammertsma, AA; Oprea-Lager, DE; Schuit, RC; Schwarte, LA; van den Eertwegh, AJ; van Moorselaar, RJ; Verwer, EE; Windhorst, AD, 2015) |
"multi-parametric MRI in the prostate cancer relapse." | 1.42 | (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer. ( Cozar, M; Escobar, M; Garcia, JR; Moragas, M; Romera, N; Soler, M, 2015) |
"A total of 72 patients with nodal prostate cancer relapse after primary therapy underwent pelvic and/or retroperitoneal salvage lymph node dissection." | 1.40 | Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography. ( Drendel, V; Grosu, AL; Henne, K; Hölz, S; Jandausch, A; Jilg, CA; Krauss, T; Reske, SN; Rischke, HC; Schultze-Seemann, W; Vach, W; Weber, WA; Wieser, G, 2014) |
"Documented local recurrence and pelvic LN and bone metastases was present in 61 of 87 (70." | 1.40 | Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. ( Froemming, AT; Hagen, CE; Kawashima, A; Kitajima, K; Murphy, RC; Nathan, MA; Takahashi, N, 2014) |
"To evaluate, in prostate cancer (PCa) patients the potential of (11)C-choline PET/CT as a guide to helical tomotherapy (HTT) of lymph-node (LN) relapses with simultaneous integrated boost (SIB)." | 1.40 | (11)C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients. ( Berardi, G; Busnardo, E; Crivellaro, C; Di Muzio, N; Fiorino, C; Fodor, A; Gianolli, L; Giovacchini, G; Incerti, E; Kirienko, M; Messa, C; Picchio, M, 2014) |
"Salvage surgery for prostate cancer is a fascinating but controversial approach." | 1.40 | First case of 18F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative 11C-choline PET/CT: new imaging techniques may expand pioneering approaches. ( Bianchi, L; Borghesi, M; Brunocilla, E; Cevenini, M; Concetti, S; Fanti, S; Gentile, G; Martorana, G; Molinaroli, E; Nanni, C; Schiavina, R, 2014) |
"1%), by requesting 15 frequent items of adverse events from the Common-Terminology-Criteria for Adverse Events Version 4." | 1.40 | Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer. ( Grosu, AL; Henne, K; Jilg, CA; Kirste, S; Leifert, A; Rischke, HC; Schlager, D; Schnell, D; Schultze-Seemann, W; Volegova-Neher, N; Wieser, G, 2014) |
"Patients with prostate cancer with prostate specific antigen (PSA) levels between 20 and 99 ng/mL and/or Gleason score 8-10 tumours, planned for treatment with curative intent based on routine staging with a negative or inconclusive bone scan, were further investigated with a (18)F-fluorocholine and a (18)F-fluoride PET/CT." | 1.38 | Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer. ( Ahlgren, G; Almquist, H; Bratt, O; Kjölhede, H; Liedberg, F; Lyttkens, K; Ohlsson, T, 2012) |
"Twenty high-risk prostate cancer patients underwent a pelvic SPECT acquisition following a transrectal ultrasound guided injection of 99mTc-Nanocoll into the prostate." | 1.38 | Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT. ( Buchegger, F; Chouiter, A; Dipasquale, G; Miralbell, R; Namy, S; Ratib, O; Steiner, C; Vees, H; Velazquez, M; Zilli, T, 2012) |
"Fourteen patients with prostate cancer underwent DWI at 1." | 1.37 | Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer. ( Beer, AJ; Eiber, M; Gaa, J; Ganter, C; Holzapfel, K; Krause, BJ; Kübler, H; Maurer, T; Souvatzoglou, M; Weirich, G; Wester, HJ, 2011) |
"62 patients with stage 1 cervical cancer were scanned at 1." | 1.36 | Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer. ( Bridges, J; DeSouza, NM; Giles, S; Ind, T; Morgan, VA; Payne, GS; Schmidt, M, 2010) |
"ER negative breast cancer was more aggressive, with larger tumor size, more non-mass-type enhancement lesions, and a higher percentage showing enlarged axillary nodes on MRI." | 1.35 | Estrogen receptor and breast MR imaging features: a correlation study. ( Baek, HM; Chen, JH; Nalcioglu, O; Su, MY, 2008) |
"Choline peak in vivo is a specific but not sensitive marker of malignancy." | 1.33 | Evaluation of spectral selected press sequence in breast lesion characterization. ( Bao, RX; Liu, PF; Lu, H; Sun, F, 2006) |
"Prostate cancer is known for its difficulties in preoperative staging of pelvic lymph nodes by conventional imaging techniques." | 1.32 | Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. ( de Jong, IJ; Elsinga, PH; Mensink, HJ; Pruim, J; Vaalburg, W, 2003) |
"11C-choline PET was very effective in detecting lymph node metastases in the mediastinum originating from NSCLC, with a sensitivity of 100%." | 1.31 | Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. ( Hara, T; Inagaki, K; Kosaka, N; Morita, T, 2000) |
"More brain metastases were detected with (11)C-CHOL PET (23/23) than with (18)F-FDG PET (3/23)." | 1.31 | Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer. ( Elsinga, PH; Groen, HJ; Pieterman, RM; Pruim, J; Que, TH; Vaalburg, W; van Putten, JW; Willemsen, AT, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (1.94) | 18.2507 |
2000's | 24 (23.30) | 29.6817 |
2010's | 73 (70.87) | 24.3611 |
2020's | 4 (3.88) | 2.80 |
Authors | Studies |
---|---|
Bjöersdorff, M | 2 |
Puterman, C | 2 |
Oddstig, J | 1 |
Amidi, J | 2 |
Zackrisson, S | 1 |
Kjölhede, H | 4 |
Bjartell, A | 2 |
Wollmer, P | 1 |
Trägårdh, E | 2 |
Andrews, JR | 1 |
Ahmed, ME | 1 |
Sharma, V | 1 |
Britton, C | 1 |
Stish, B | 1 |
Phillips, R | 1 |
Kendi, AT | 1 |
Joshi, VB | 1 |
Sood, A | 1 |
Tollefson, MK | 1 |
Boorjian, SA | 1 |
Karnes, RJ | 4 |
Kwon, ED | 3 |
Dias, N | 1 |
Colandrea, G | 1 |
Botelho, F | 1 |
Rodriguez-Sanchez, L | 1 |
Barbé, Y | 1 |
Macek, P | 1 |
Cathelineau, X | 1 |
Anand, A | 1 |
Soller, W | 1 |
Jiborn, T | 1 |
Bouman-Wammes, EW | 1 |
van Dodewaard-De Jong, JM | 1 |
Dahele, M | 1 |
Cysouw, MCF | 1 |
Hoekstra, OS | 2 |
van Moorselaar, RJA | 1 |
Piet, MAH | 1 |
Verberne, HJ | 1 |
Bins, AD | 1 |
Verheul, HMW | 1 |
Slotman, BJ | 1 |
Oprea-Lager, DE | 2 |
Van den Eertwegh, AJM | 1 |
Incerti, E | 5 |
Gangemi, V | 1 |
Mapelli, P | 3 |
Deantoni, CL | 1 |
Giovacchini, G | 6 |
Fallanca, F | 1 |
Fodor, A | 5 |
Ciarmiello, A | 1 |
Baldari, S | 1 |
Gianolli, L | 4 |
Di Muzio, N | 4 |
Picchio, M | 9 |
Franzese, C | 1 |
Lopci, E | 1 |
Di Brina, L | 1 |
D'Agostino, GR | 1 |
Navarria, P | 1 |
Mancosu, P | 1 |
Tomatis, S | 1 |
Chiti, A | 1 |
Scorsetti, M | 1 |
Kim, SJ | 1 |
Koo, PJ | 1 |
Pak, K | 1 |
Kim, IJ | 1 |
Kim, K | 1 |
Metser, U | 1 |
Berlin, A | 1 |
Halankar, J | 1 |
Murphy, G | 1 |
Jhaveri, KS | 1 |
Ghai, S | 1 |
Tau, N | 1 |
Lancia, A | 1 |
Ceci, F | 3 |
Hoyer, M | 1 |
Jereczek-Fossa, BA | 2 |
Ost, P | 1 |
Castellucci, P | 4 |
Ingrosso, G | 1 |
Kitajima, K | 2 |
Yamamoto, S | 1 |
Odawara, S | 1 |
Kobayashi, K | 1 |
Fujiwara, M | 1 |
Kamikonya, N | 1 |
Fukushima, K | 1 |
Nakanishi, Y | 1 |
Hashimoto, T | 1 |
Yamada, Y | 1 |
Suzuki, T | 1 |
Kanematsu, A | 1 |
Nojima, M | 1 |
Yamakado, K | 1 |
Vaugier, L | 1 |
Palpacuer, C | 1 |
Rio, E | 1 |
Goineau, A | 1 |
Pasquier, D | 1 |
Buthaud, X | 1 |
De Laroche, G | 1 |
Beckendorf, V | 1 |
Sargos, P | 1 |
Créhange, G | 3 |
Pommier, P | 1 |
Loos, G | 1 |
Hasbini, A | 1 |
Latorzeff, I | 1 |
Silva, M | 1 |
Denis, F | 1 |
Lagrange, JL | 1 |
Campion, L | 1 |
Supiot, S | 1 |
Huang, SM | 1 |
Yin, L | 1 |
Yue, JL | 1 |
Li, YF | 1 |
Yang, Y | 1 |
Lin, ZC | 1 |
Schwarzenböck, SM | 1 |
Kurth, J | 1 |
Gocke, Ch | 1 |
Kuhnt, T | 1 |
Hildebrandt, G | 1 |
Krause, BJ | 6 |
Passoni, NM | 1 |
Suardi, N | 3 |
Abdollah, F | 2 |
Messa, C | 5 |
Freschi, M | 3 |
Montorsi, F | 3 |
Briganti, A | 3 |
Hodolič, M | 1 |
Maffione, AM | 1 |
Fettich, J | 1 |
Gubina, B | 1 |
Cimitan, M | 2 |
Rubello, D | 2 |
Wetter, A | 1 |
Lipponer, C | 1 |
Nensa, F | 1 |
Heusch, P | 1 |
Rübben, H | 1 |
Altenbernd, JC | 1 |
Schlosser, T | 1 |
Bockisch, A | 1 |
Pöppel, T | 1 |
Lauenstein, T | 1 |
Nagarajah, J | 1 |
Ahlgren, G | 2 |
Almquist, H | 2 |
Liedberg, F | 2 |
Lyttkens, K | 2 |
Ohlsson, T | 2 |
Bratt, O | 2 |
Heck, MM | 2 |
Souvatzoglou, M | 5 |
Retz, M | 1 |
Nawroth, R | 1 |
Kübler, H | 3 |
Maurer, T | 3 |
Thalgott, M | 1 |
Gramer, BM | 1 |
Weirich, G | 4 |
Rondak, IC | 1 |
Rummeny, EJ | 2 |
Schwaiger, M | 4 |
Gschwend, JE | 2 |
Krause, B | 1 |
Eiber, M | 3 |
Schiavina, R | 5 |
Concetti, S | 1 |
Brunocilla, E | 2 |
Nanni, C | 2 |
Borghesi, M | 1 |
Gentile, G | 1 |
Cevenini, M | 1 |
Bianchi, L | 2 |
Molinaroli, E | 1 |
Fanti, S | 5 |
Martorana, G | 4 |
Murphy, RC | 1 |
Nathan, MA | 2 |
Froemming, AT | 1 |
Hagen, CE | 1 |
Takahashi, N | 1 |
Kawashima, A | 1 |
Jilg, CA | 3 |
Schultze-Seemann, W | 2 |
Drendel, V | 1 |
Vach, W | 3 |
Wieser, G | 2 |
Krauss, T | 2 |
Jandausch, A | 1 |
Hölz, S | 1 |
Henne, K | 3 |
Reske, SN | 3 |
Grosu, AL | 3 |
Weber, WA | 1 |
Rischke, HC | 3 |
Berardi, G | 2 |
Busnardo, E | 3 |
Crivellaro, C | 1 |
Fiorino, C | 3 |
Kirienko, M | 3 |
Lépinoy, A | 1 |
Cochet, A | 2 |
Cueff, A | 1 |
Cormier, L | 2 |
Martin, E | 1 |
Maingon, P | 1 |
Bosset, JF | 1 |
Brunotte, F | 2 |
Garcia, JR | 2 |
Jorcano, S | 1 |
Soler, M | 2 |
Linero, D | 1 |
Moragas, M | 2 |
Riera, E | 1 |
Miralbell, R | 2 |
Lomeña, F | 1 |
Vag, T | 1 |
Beer, AJ | 2 |
Holzapfel, K | 2 |
Leifert, A | 1 |
Schnell, D | 1 |
Kirste, S | 1 |
Volegova-Neher, N | 2 |
Schlager, D | 1 |
Murphy, CR | 1 |
Bergstralh, EJ | 1 |
DiMonte, G | 1 |
Cheville, JC | 1 |
Lowe, VJ | 2 |
Mynderse, LA | 2 |
Kanoun, S | 1 |
Humbert, O | 1 |
Walker, PM | 1 |
Graziani, T | 2 |
Pultrone, C | 2 |
Eugenio, B | 1 |
Colletti, PM | 1 |
Beheshti, M | 2 |
Kunit, T | 1 |
Haim, S | 1 |
Zakavi, R | 1 |
Schiller, C | 1 |
Stephens, A | 1 |
Dinkelborg, L | 1 |
Langsteger, W | 3 |
Loidl, W | 2 |
Goldstein, J | 1 |
Even-Sapir, E | 1 |
Ben-Haim, S | 1 |
Saad, A | 1 |
Spieler, B | 1 |
Davidson, T | 1 |
Berger, R | 1 |
Weiss, I | 1 |
Appel, S | 1 |
Lawrence, YR | 1 |
Symon, Z | 1 |
Romera, N | 1 |
Cozar, M | 1 |
Escobar, M | 1 |
Evangelista, L | 3 |
Zattoni, F | 5 |
Guttilla, A | 2 |
Saladini, G | 1 |
Van den Bergh, L | 2 |
Lerut, E | 2 |
Haustermans, K | 2 |
Deroose, CM | 2 |
Oyen, R | 2 |
Isebaert, S | 1 |
Budiharto, T | 2 |
Ameye, F | 2 |
Mottaghy, FM | 2 |
Bogaerts, K | 2 |
Van Poppel, H | 2 |
Joniau, S | 2 |
Pinaquy, JB | 2 |
Fernandez, P | 1 |
Pasticier, G | 2 |
Parrens, M | 1 |
De Clermont, H | 2 |
Allard, JB | 1 |
Cornelis, F | 1 |
Verwer, EE | 1 |
van den Eertwegh, AJ | 1 |
van Moorselaar, RJ | 1 |
Windhorst, AD | 1 |
Schwarte, LA | 1 |
Hendrikse, NH | 1 |
Schuit, RC | 1 |
Lammertsma, AA | 1 |
Boellaard, R | 1 |
Piccardo, A | 1 |
Massollo, M | 1 |
Bandelloni, R | 1 |
Arlandini, A | 1 |
Foppiani, L | 1 |
Alongi, P | 1 |
Eiberger, AK | 1 |
Zanoni, L | 1 |
Lodi, F | 2 |
Malizia, C | 1 |
Ferrari, M | 1 |
Rigatti, P | 4 |
Fonti, C | 1 |
Hegemann, NS | 1 |
Wenter, V | 1 |
Spath, S | 1 |
Kusumo, N | 1 |
Li, M | 3 |
Bartenstein, P | 3 |
Fendler, WP | 1 |
Stief, C | 1 |
Belka, C | 1 |
Ganswindt, U | 1 |
Dell'Oca, I | 1 |
Cozzarini, C | 1 |
Mangili, P | 1 |
Pasetti, M | 1 |
Calandrino, R | 1 |
Di Muzio, NG | 1 |
Polverari, G | 1 |
Lima, GM | 1 |
Morganti, AG | 1 |
Ardizzoni, A | 1 |
Novara, G | 1 |
Lowe, V | 1 |
Schwenck, J | 1 |
Rempp, H | 1 |
Reischl, G | 1 |
Kruck, S | 1 |
Stenzl, A | 1 |
Nikolaou, K | 1 |
Pfannenberg, C | 1 |
la Fougère, C | 1 |
Hugentobler, A | 1 |
Gilbeau, L | 1 |
Talbot, JN | 1 |
Gauthé, M | 1 |
Beauregard, JM | 1 |
Beaulieu, A | 1 |
Parker, WP | 1 |
Evans, JD | 1 |
Stish, BJ | 1 |
Park, SS | 1 |
Olivier, K | 1 |
Choo, R | 1 |
Welch, BT | 1 |
Pisansky, TM | 1 |
Davis, BJ | 1 |
Van den Broeck, B | 1 |
De Maeseneer, D | 1 |
De Gersem, R | 1 |
De Man, K | 1 |
Rinnab, L | 1 |
Simon, J | 1 |
Volkmer, BG | 1 |
de Petriconi, R | 1 |
Hautmann, RE | 1 |
Wittbrodt, M | 1 |
Egghart, G | 1 |
Moeller, P | 1 |
Blumstein, N | 1 |
Reske, S | 1 |
Kuefer, R | 1 |
Samanes Gajate, AM | 1 |
Fazio, F | 3 |
Payne, GS | 1 |
Schmidt, M | 1 |
Morgan, VA | 1 |
Giles, S | 1 |
Bridges, J | 1 |
Ind, T | 1 |
DeSouza, NM | 1 |
Steuber, T | 1 |
Schlomm, T | 1 |
Heinzer, H | 1 |
Zacharias, M | 1 |
Ahyai, S | 1 |
Chun, KF | 1 |
Haese, A | 1 |
Klutmann, S | 1 |
Köllermann, J | 1 |
Sauter, G | 1 |
Mester, J | 1 |
Mikecz, P | 1 |
Fisch, M | 1 |
Huland, H | 1 |
Graefen, M | 1 |
Salomon, G | 1 |
Poulsen, MH | 2 |
Bouchelouche, K | 2 |
Gerke, O | 2 |
Petersen, H | 2 |
Svolgaard, B | 1 |
Marcussen, N | 2 |
Svolgaard, N | 2 |
Ogren, M | 1 |
Høilund-Carlsen, PF | 2 |
Geertsen, U | 2 |
Walter, S | 2 |
Winter, A | 1 |
Uphoff, J | 1 |
Henke, RP | 1 |
Wawroschek, F | 1 |
Ganter, C | 1 |
Wester, HJ | 1 |
Gaa, J | 1 |
Yeung, DK | 3 |
Fong, KY | 1 |
Chan, QC | 1 |
King, AD | 2 |
Dundee, PE | 1 |
Hutton, AC | 1 |
Eden, CG | 1 |
Jansen, JF | 1 |
Schöder, H | 2 |
Lee, NY | 1 |
Stambuk, HE | 1 |
Wang, Y | 1 |
Fury, MG | 1 |
Patel, SG | 1 |
Pfister, DG | 1 |
Shah, JP | 1 |
Koutcher, JA | 1 |
Shukla-Dave, A | 1 |
Beltramo, G | 1 |
Fariselli, L | 1 |
Fodor, C | 1 |
Santoro, L | 1 |
Vavassori, A | 1 |
Zerini, D | 1 |
Gherardi, F | 1 |
Ascione, C | 1 |
Bossi-Zanetti, I | 1 |
Mauro, R | 1 |
Bregantin, A | 1 |
Bianchi, LC | 1 |
De Cobelli, O | 1 |
Orecchia, R | 1 |
Mottaghy, F | 1 |
Würschmidt, F | 1 |
Petersen, C | 1 |
Wahl, A | 1 |
Dahle, J | 1 |
Kretschmer, M | 1 |
Pürschel, A | 1 |
Thamm, R | 1 |
Schuster, T | 1 |
Buck, AK | 1 |
Zimmermann, F | 1 |
Molls, M | 1 |
Geinitz, H | 1 |
Zengerling, F | 1 |
Schrader, AJ | 1 |
Schrader, M | 1 |
Jentzmik, F | 1 |
Da Pozzo, LF | 1 |
Tutolo, M | 1 |
Villa, L | 1 |
Gallina, A | 1 |
Capitanio, U | 1 |
Scattoni, V | 3 |
Colombo, R | 1 |
Guazzoni, G | 1 |
Bauman, G | 1 |
Belhocine, T | 1 |
Kovacs, M | 1 |
Ward, A | 1 |
Rachinsky, I | 1 |
Contractor, K | 1 |
Challapalli, A | 1 |
Barwick, T | 1 |
Winkler, M | 1 |
Hellawell, G | 1 |
Hazell, S | 1 |
Tomasi, G | 1 |
Al-Nahhas, A | 1 |
Kenny, LM | 1 |
Tadrous, P | 1 |
Coombes, RC | 1 |
Aboagye, EO | 1 |
Mangar, S | 1 |
Graute, V | 1 |
Jansen, N | 1 |
Ubleis, C | 1 |
Seitz, M | 2 |
Hartenbach, M | 1 |
Scherr, MK | 1 |
Thieme, S | 1 |
Cumming, P | 1 |
Klanke, K | 1 |
Tiling, R | 1 |
Hacker, M | 2 |
Peng, Z | 2 |
Liu, Q | 4 |
Han, M | 1 |
Yao, S | 2 |
Opercan, K | 1 |
Schmidt, S | 1 |
Herrmann, K | 1 |
Stollfuss, J | 1 |
Haller, B | 1 |
Treiber, U | 1 |
Fortuin, AS | 1 |
Deserno, WM | 1 |
Meijer, HJ | 1 |
Jager, GJ | 1 |
Takahashi, S | 1 |
Debats, OA | 1 |
Schick, C | 1 |
van Oort, I | 1 |
Witjes, AJ | 1 |
Hoogeveen, YL | 1 |
van Lin, EN | 2 |
Barentsz, JO | 2 |
Steffansen, SI | 1 |
Vees, H | 1 |
Steiner, C | 1 |
Dipasquale, G | 1 |
Chouiter, A | 1 |
Zilli, T | 1 |
Velazquez, M | 1 |
Namy, S | 1 |
Ratib, O | 1 |
Buchegger, F | 1 |
Tilki, D | 1 |
Reich, O | 1 |
Graser, A | 1 |
Silchinger, J | 1 |
Becker, AJ | 1 |
Khoder, W | 1 |
Stief, CG | 1 |
Muzzio, PC | 1 |
Sun, J | 1 |
Yang, WT | 1 |
Tse, GM | 2 |
de Jong, IJ | 1 |
Pruim, J | 2 |
Elsinga, PH | 2 |
Vaalburg, W | 2 |
Mensink, HJ | 1 |
Khan, N | 1 |
Oriuchi, N | 1 |
Zhang, H | 1 |
Higuchi, T | 1 |
Tian, M | 1 |
Inoue, T | 1 |
Sato, N | 1 |
Endo, K | 1 |
Ahuja, AT | 1 |
Leung, SF | 1 |
van Hasselt, AC | 1 |
Heinisch, M | 1 |
Fogelman, I | 1 |
Maeda, T | 2 |
Tateishi, U | 2 |
Komiyama, M | 1 |
Fujimoto, H | 1 |
Watanabe, S | 1 |
Terauchi, T | 2 |
Moriyama, N | 2 |
Arai, Y | 1 |
Sugimura, K | 1 |
Kakizoe, T | 2 |
Häcker, A | 1 |
Jeschke, S | 1 |
Leeb, K | 1 |
Prammer, K | 1 |
Ziegerhofer, J | 1 |
Sega, W | 1 |
Janetschek, G | 1 |
Lu, H | 1 |
Liu, PF | 1 |
Bao, RX | 1 |
Sun, F | 1 |
Bochner, B | 1 |
Oyama, N | 1 |
Roscigno, M | 1 |
Da Pozzo, L | 1 |
Bocciardi, A | 1 |
Heijmink, SW | 1 |
Scheenen, TW | 1 |
Fütterer, JJ | 1 |
Klomp, DW | 1 |
Heesakkers, RA | 1 |
Hulsbergen-van de Kaa, CA | 1 |
Heerschap, A | 1 |
Kanou, D | 1 |
Daisaki, H | 1 |
Moriya, Y | 1 |
Greco, C | 1 |
Cascini, GL | 1 |
Tamburrini, O | 1 |
Sardanelli, F | 1 |
Fausto, A | 1 |
Podo, F | 1 |
Chen, JH | 1 |
Baek, HM | 1 |
Nalcioglu, O | 1 |
Su, MY | 1 |
Chun, FK | 1 |
Corti, B | 1 |
Franceschelli, A | 1 |
Sanguedolce, F | 1 |
Bertaccini, A | 1 |
Farsad, M | 1 |
Grigioni, WF | 1 |
Star-Lack, J | 1 |
Spielman, D | 1 |
Adalsteinsson, E | 2 |
Kurhanewicz, J | 1 |
Terris, DJ | 2 |
Vigneron, DB | 1 |
Malycha, P | 1 |
Mountford, C | 1 |
Star-Lack, JM | 1 |
Adam, MF | 1 |
Pinto, HA | 1 |
Brown, JM | 1 |
Spielman, DM | 1 |
Hara, T | 1 |
Inagaki, K | 1 |
Kosaka, N | 1 |
Morita, T | 1 |
Kotzerke, J | 1 |
Prang, J | 1 |
Neumaier, B | 1 |
Volkmer, B | 1 |
Guhlmann, A | 1 |
Kleinschmidt, K | 1 |
Hautmann, R | 1 |
Pieterman, RM | 1 |
Que, TH | 1 |
van Putten, JW | 1 |
Willemsen, AT | 1 |
Groen, HJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) PET/CT Utilizing the High Resolution Digital Philips Vereos Scanner, in Patients With Biochemical Recurrence After Radical Prostatectomy[NCT04234399] | 22 participants (Actual) | Observational | 2020-03-01 | Active, not recruiting | |||
A Multi-center, Open-label, Single Arm Phase III Clinical Trial for the Diagnostic Efficacy Assessment and Safety Evaluation by [18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer[NCT05936658] | Phase 3 | 89 participants (Anticipated) | Interventional | 2023-05-08 | Recruiting | ||
BEACON - A Phase I/II Study of High-dose-rate Brachytherapy and External Beam and Short-term Androgen Deprivation COmbined for the Treatment of Men With Fluciclovine PET Pelvic Nodal Uptake in Locally Recurrent Prostate Cancer After Prior Definitive Radio[NCT03553602] | Phase 1/Phase 2 | 24 participants (Anticipated) | Interventional | 2018-05-29 | Recruiting | ||
Pilot Comparative Study of PET/MR and PET/CT With Different Tracers (18F-FDG and 68Gallium Citrate) in the Diagnosis of Periprosthetic Joint Infection[NCT02855190] | 30 participants (Anticipated) | Interventional | 2016-01-31 | Recruiting | |||
Phase III Multicentre Prospective Comparative Study of Detection Rate of 18F-JK-PSMA-7 and of 18F-fluorocholine in Patients With Biochemical Recurrence of Prostate Cancer After Previous Treatment With Curative Intent[NCT05622162] | Phase 3 | 106 participants (Anticipated) | Interventional | 2022-11-30 | Not yet recruiting | ||
Evaluation of [18F] Fluorocholine PET/CT for Detection of Regional Lymph Node Metastases From Prostate Cancer[NCT00670527] | 205 participants (Anticipated) | Interventional | 2008-01-31 | Recruiting | |||
All-in-One Prostate Cancer Staging With MRI[NCT06071195] | 400 participants (Anticipated) | Observational | 2021-12-22 | Recruiting | |||
Clinical Value of [18]Fluoroethylcholine Positron-Emission-Tomography Combined With Endorectal Magnetic Resonance Imaging by Software Fusion for Pre-therapeutic Staging of Prostate Cancer[NCT00520546] | Phase 3 | 44 participants (Actual) | Interventional | 2007-12-31 | Completed | ||
F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer Treated by Abiraterone Acetate or Enzalutamide[NCT01981707] | Phase 2/Phase 3 | 12 participants (Actual) | Interventional | 2013-12-31 | Terminated (stopped due to enrollment default) | ||
A Phase 1 Pilot Study of 99mTc-MIP-1404 Single Photon Emission Computed Tomography (SPECT)/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection (PLND)[NCT01572701] | Phase 1 | 8 participants (Actual) | Interventional | 2012-01-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
PET positive lesions (n=128) were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative and positive predictive values were determined. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
Intervention | lesions (Number) | |||||
---|---|---|---|---|---|---|
True positive | False positive | True negative | False negative | Total true | Total false | |
FEC-PET | 59 | 26 | 19 | 24 | 78 | 50 |
Magnetic Resonance Imaging (MRI) | 40 | 27 | 18 | 43 | 58 | 70 |
PET/MRI | 55 | 8 | 37 | 28 | 92 | 36 |
PET positive lesions in patients with Gleason >6(3+3),n=43 were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative & positive predictive values were determined. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
Intervention | lesions (Number) | |||||
---|---|---|---|---|---|---|
True positive | False positive | True negative | False negative | Total true | Total false | |
FEC-PET | 27 | 5 | 8 | 3 | 35 | 8 |
Magnetic Resonance Imaging (MRI) | 22 | 9 | 4 | 8 | 26 | 17 |
PET/MRI | 27 | 1 | 11 | 4 | 38 | 5 |
PET positive lesions were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative and positive predictive values were determined without malign lesions <=5mm. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
Intervention | lesions (Number) | |||||
---|---|---|---|---|---|---|
True positive | False positive | True negative | False negative | Total true | Total false | |
FEC-PET | 48 | 24 | 18 | 8 | 66 | 32 |
Magnetic Resonance Imaging (MRI) | 37 | 26 | 16 | 19 | 53 | 45 |
PET/MRI | 48 | 8 | 32 | 10 | 80 | 18 |
PET positive lesions were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. At least 1 histological confirmed cancer lesion has to be detected by each of the 3 methods to be patient based true positive. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
Intervention | participants (Number) | |||||
---|---|---|---|---|---|---|
True Positive | False Positive | True Negative | False Negative | Total True | Total False | |
[18F]Fluoroethylcholine Positron-Emission-Tomography (FEC-PET) | 36 | 1 | 0 | 1 | 36 | 2 |
Magnetic Resonance Imaging (MRI) | 26 | 1 | 0 | 11 | 27 | 11 |
PositronEmissionTomography/MagneticResonanceImaging (PET/MRI) | 35 | 0 | 1 | 2 | 36 | 2 |
13 reviews available for choline and Lymph Node Metastasis
Article | Year |
---|---|
Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer.
Topics: Choline; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Pos | 2022 |
Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis.
Topics: Acetates; Carbon; Carbon Radioisotopes; Carcinoma, Transitional Cell; Choline; Humans; Likelihood Fu | 2018 |
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row : Nodal oligorecurrent prostate cancer.
Topics: Choline; Fluorine Radioisotopes; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymphatic Metastas | 2019 |
Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer.
Topics: Aged; Choline; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron | 2018 |
Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.
Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positro | 2013 |
[Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment].
Topics: Adenocarcinoma; Brachytherapy; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglu | 2014 |
Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: a systematic review and meta-analysis.
Topics: Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Positr | 2016 |
[Diagnostic relevance of choline-PET / CT in patients with prostate cancer].
Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Disease Progression; Fluorine Radioisotopes; Humans; | 2012 |
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas | 2012 |
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas | 2012 |
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas | 2012 |
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas | 2012 |
Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis.
Topics: Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Lymph Nodes; Lymphatic Metastasis; Ma | 2013 |
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeo | 2006 |
Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse?
Topics: Adenocarcinoma; Carbon Radioisotopes; Choline; Clinical Trials as Topic; Humans; Lymphatic Metastasi | 2008 |
MR spectroscopy of the breast.
Topics: Breast; Breast Neoplasms; Choline; Female; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; | 2008 |
8 trials available for choline and Lymph Node Metastasis
Article | Year |
---|---|
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07).
Topics: Aged; Androgen Antagonists; Choline; Digestive System; Dose Fractionation, Radiation; Fluorine Radio | 2019 |
BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study).
Topics: Aged; Aged, 80 and over; Bone Marrow; Choline; Fluorodeoxyglucose F18; Glutarates; Humans; Lymphatic | 2015 |
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan | 2016 |
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan | 2016 |
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan | 2016 |
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan | 2016 |
[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes.
Topics: Aged; Carcinoma; Choline; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Sta | 2011 |
Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer.
Topics: Adult; Aged; Carbon Radioisotopes; Choline; Contrast Media; Female; Humans; Lung Neoplasms; Lymph No | 2012 |
A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Choline | 2003 |
Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.
Topics: Aged; Choline; Humans; Laparoscopy; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomog | 2006 |
In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Choline; Creatine; Head and Neck Neoplasms; Humans; Lactic Ac | 2000 |
82 other studies available for choline and Lymph Node Metastasis
Article | Year |
---|---|
Detection of lymph node metastases in patients with prostate cancer: Comparing conventional and digital [
Topics: Choline; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Positron Emission Tomogr | 2022 |
Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer.
Topics: Androgen Antagonists; Androgens; Choline; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, L | 2022 |
A retrospective study assessing the accuracy of [18F]-fluorocholine PET/CT for primary staging of lymph node metastases in intermediate and high-risk prostate cancer patients undergoing robotic-assisted laparoscopic prostatectomy with extended lymph node
Topics: Choline; Humans; Laparoscopy; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Staging; Pos | 2021 |
Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Choline; Combined Mo | 2017 |
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis | 2017 |
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer.
Topics: Aged; Carbon Radioisotopes; Choline; Disease-Free Survival; Humans; Kallikreins; Kaplan-Meier Estima | 2017 |
Topics: Aged; Aged, 80 and over; Choline; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mi | 2018 |
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma | 2018 |
Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series.
Topics: Aged; Androgen Antagonists; Carbon Radioisotopes; Choline; Humans; Lymph Node Excision; Lymph Nodes; | 2014 |
Metastatic prostate cancer proven by 18F-FCH PET/CT staging scan in patient with normal PSA but high PSA doubling time.
Topics: Choline; Fluorine Radioisotopes; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission | 2013 |
Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer: comparison with [(18)F]choline PET/CT.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Humans; Lymphatic Metastasis; Magnetic Resonance I | 2014 |
¹⁸F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.
Topics: Aged; Biomarkers, Tumor; Choline; Cohort Studies; Fluorine Radioisotopes; Humans; Lymph Node Excisio | 2014 |
Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; | 2014 |
First case of 18F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative 11C-choline PET/CT: new imaging techniques may expand pioneering approaches.
Topics: Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Humans; Lymph Node Excision; Lymphati | 2014 |
Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carbon Radioisotopes; Choline; Humans; Image Processing, | 2014 |
Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplas | 2014 |
(11)C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Feasibility Studies; Humans; Lymphatic Metas | 2014 |
Pattern of occult nodal relapse diagnosed with (18)F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy.
Topics: Choline; Fluorine Radioisotopes; Humans; Kallikreins; Lymph Nodes; Lymphatic Metastasis; Male; Multi | 2014 |
11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning.
Topics: Aged; Biopsy; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Mid | 2015 |
Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT.
Topics: Aged; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Humans; Lymph Nodes; Lymp | 2014 |
Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer.
Topics: Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Lymph Node Excision; Lymphatic | 2014 |
Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle | 2015 |
11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma; Choline; Female; Humans; Lymphatic | 2015 |
Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Brachytherapy; Carbon Radioisotopes; Choline; Humans; Lymph | 2017 |
(11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Carbon Radioisotopes; Choline; Combined Modality Therapy; Humans; Ly | 2015 |
Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A
Topics: Abdomen; Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Lymph Nod | 2015 |
Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.
Topics: Aged; Biopsy; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Humans; Lymph Nod | 2015 |
Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer.
Topics: Adenocarcinoma; Anthracosis; Choline; False Positive Reactions; Humans; Lymphatic Metastasis; Male; | 2015 |
Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT.
Topics: Adenocarcinoma; Aged; Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emis | 2015 |
Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.
Topics: Aged; Calibration; Choline; Humans; Kinetics; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; | 2015 |
Lymph Node Metastasis from Tall-Cell Thyroid Cancer Negative on 18F-FDG PET/CT and Detected by 18F-Choline PET/CT.
Topics: Aged; Choline; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Pos | 2015 |
Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Disease-Free Survival; Female; Humans; Image | 2015 |
PET/CT and MRI directed extended salvage radiotherapy in recurrent prostate cancer with lymph node metastases.
Topics: Aged; Choline; Cohort Studies; Contrast Media; Disease Progression; Follow-Up Studies; Humans; Lymph | 2016 |
Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment.
Topics: Aged; Aged, 80 and over; Choline; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neop | 2016 |
Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer.
Topics: Aged; Aged, 80 and over; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imagin | 2017 |
(11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series.
Topics: Aged; Aged, 80 and over; Choline; Disease-Free Survival; Feasibility Studies; Humans; Italy; Lymphat | 2016 |
Comparison of
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotop | 2017 |
18F-Fluorocholine PET/CT of Incidental Male Breast Cancer.
Topics: Aged; Breast Neoplasms, Male; Choline; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; P | 2017 |
How we read FCH-PET/CT for prostate cancer.
Topics: Aged; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; M | 2016 |
Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.
Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged | 2017 |
Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT.
Topics: Adenoma; Carcinoma; Choline; Diagnosis, Differential; Humans; Lymphatic Metastasis; Male; Middle Age | 2017 |
[11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.
Topics: Aged; Biomarkers; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neo | 2008 |
Increased C-11 choline uptake in pagetic bone in a patient with coexisting skeletal metastases from prostate cancer.
Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Cell Proliferation; Choline; Diagnosis, Differential; Fe | 2008 |
Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Cell Differentiation; Choline; Cohort Studies; Diffusion Magnetic Re | 2010 |
[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study.
Topics: Choline; False Negative Reactions; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Positron | 2010 |
[18F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.
Topics: Aged; Choline; Epidemiologic Methods; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; | 2010 |
First results of [11C]choline PET/CT-guided secondary lymph node surgery in patients with PSA failure and single lymph node recurrence after radical retropubic prostatectomy.
Topics: Aged; Carbon Radioisotopes; Choline; Feasibility Studies; Germany; Humans; Lymph Node Excision; Lymp | 2010 |
Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer.
Topics: Aged; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Follow-Up Studies; Humans | 2011 |
Chemical shift imaging in the head and neck at 3T: initial results.
Topics: Adult; Aged; Choline; Female; Head; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assi | 2010 |
[¹⁸F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.
Topics: Choline; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Positron-Emission Tomography; Prostatic Ne | 2011 |
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Squam | 2012 |
Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Carbon Radioisotopes; Choline; Disease-Free Survival; | 2012 |
Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Humans; L | 2011 |
Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Logistic Models; Lymphatic Metastasis; Male; Middle Age | 2011 |
Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.
Topics: Aged; Choline; Disease-Free Survival; Feasibility Studies; Humans; Italy; Kaplan-Meier Estimate; Lym | 2011 |
Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Choline Kinase; Humans; Immunohistochemistry | 2011 |
Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy.
Topics: Aged; Aged, 80 and over; Choline; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kinetics; Lymph | 2012 |
Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma; Choline; Cystectomy; Female; Humans | 2012 |
Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases.
Topics: Aged; Carbon Radioisotopes; Choline; Contrast Media; Dextrans; Humans; Lymph Nodes; Lymphatic Metast | 2012 |
Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
Topics: Aged; Bone Neoplasms; Choline; Fluorides; Fluorine Radioisotopes; Humans; Lymphatic Metastasis; Male | 2012 |
[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Topics: Aged; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Lymph Node Excision; Lymph Nodes; Lym | 2012 |
Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT.
Topics: Aged; Choline; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lym | 2012 |
18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.
Topics: Aged; Choline; Disease Progression; Humans; Kallikreins; Lymph Node Excision; Lymph Nodes; Lymphatic | 2013 |
Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; | 2013 |
Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; | 2002 |
Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Humans; Image Processing, Computer-Assisted; Ly | 2003 |
In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma.
Topics: Adult; Aged; Algorithms; Choline; Creatine; Data Interpretation, Statistical; Energy Metabolism; Equ | 2004 |
Distant metastasis of prostate cancer: early detection of recurrent tumor with dual-phase carbon-11 choline positron emission tomography/computed tomography in two cases.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Carbon Radioisotopes; Choline; Early Diagnosi | 2006 |
Evaluation of spectral selected press sequence in breast lesion characterization.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Female; Fibroa | 2006 |
Detection and management of isolated lymph node recurrence in patients with PSA relapse.
Topics: Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Prosta | 2007 |
Editorial comment on: Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr | 2007 |
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr | 2007 |
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr | 2007 |
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr | 2007 |
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr | 2007 |
Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy.
Topics: Adenocarcinoma; Aged; Choline; Humans; Image Processing, Computer-Assisted; Lymph Node Excision; Lym | 2007 |
A case of colon cancer detected by carbon-11 choline positron emission tomography/computed tomography: an initial report.
Topics: Adenocarcinoma; Biopsy; Carbon Radioisotopes; Choline; Colonic Neoplasms; Female; Humans; Hysterecto | 2007 |
Estrogen receptor and breast MR imaging features: a correlation study.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Female; Humans; Lymphatic | 2008 |
Editorial comment on: 11C-choline-positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
Topics: Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Nomograms; Posi | 2008 |
11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Stagi | 2008 |
In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors.
Topics: Aspartic Acid; Brain Chemistry; Brain Neoplasms; Choline; Creatine; Female; Humans; Lactic Acid; Lip | 1998 |
Magnetic resonance spectroscopy and breast cancer.
Topics: Biopsy, Needle; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Choline; Creatine; F | 1998 |
Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET.
Topics: Adult; Aged; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Choline; Female; Fluorodeoxygluco | 2000 |
Experience with carbon-11 choline positron emission tomography in prostate carcinoma.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neop | 2000 |
Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
Topics: Aged; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung N | 2002 |